Personalized Medicine

The Conference program is developed around the theme of Personalized Medicine. In the last fifty years, there has been a dramatic evolution in the treatment of cancer: from toxic, nonspecific single agents to combination chemotherapy, immunotherapy, genomic testing plus surgery and radiation. With these advances, cancer treatment is becoming much more personalized: assessing patients for hormone status, genetic markers, performance/frailty status and mode of delivery. We must balance the benefits of newer therapies with toxicity profile, cost, regimen schedules and, most importantly, what the patient wants for their treatment journey.